"/> Invitrogen™ Kit ELISA CD35 humain | B-LABO France

Invitrogen™ Kit ELISA CD35 humain

Réf. : BL-RE-094028Réf. fabricant : 18517954 10 x 96 Tests
Prix sur devis
Tarif personnalisé selon la configuration et la quantité.

Human CD35 quantitates human CD35 in serum, plasma, supernatant.

Numéro d’adhésion
C3b/C4b receptor; C3-binding protein; C3BR; C4BR; CD35; CD35 antigen; complement component (3 b/4 b) receptor 1 (Knops blood group); complement component 3 b/4 b receptor 1 (Knops blood group); complement receptor type 1; CR1; KN; Knops blood group antigen
Plage de dosage
0.2 to 50 ng/mL
Sensibilité du dosage
0.2 ng/mL
Conjugué
Biotin
Type de produit
ELISA
Marque
Invitrogen

CD35 (CR1, Complement Receptor 1) is a cell membrane-bound, monomeric glycoprotein and its primary function is to serve as the cellular receptor for C3b and C4b, the most important components of the complement system leading to clearance of foreign macromolecules. CD35 protein mediates cellular binding to particles and immune complexes that have activated complement. The CD35 complex is four different allotypes (C,A,B,D) C is 160 kDa; A is 190 kDa; B is 220 kDa and D is 250 kDa. CD35 is involved in the processing of immune complexes, promoting of binding and phagocytosis of C3b complexes and inhibition of complement activation. CD35 is on neutrophils, eosinophils, monocytes, B-cells, some NK-cells, erythrocytes, myeloid leukemias, follicular dendritic reticulum cells and is negative on basophils. Decreases in expression of CD35 protein and/or mutations in its gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus and sarcoidosis. Mutations in the CD35 gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. Alternate allele-specific splice variants encoding different isoforms of CD35 have been characterized. An additional secreted form of CD35 have also been described but has not been fully characterized.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-094028
Réf. fabricant18517954
Numéro d’adhésionC3b/C4b receptor; C3-binding protein; C3BR; C4BR; CD35; CD35 antigen; complement component (3 b/4 b) receptor 1 (Knops blood group); complement component 3 b/4 b receptor 1 (Knops blood group); complement receptor type 1; CR1; KN; Knops blood group antigen
Plage de dosage0.2 to 50 ng/mL
Sensibilité du dosage0.2 ng/mL
ConjuguéBiotin
Type de produitELISA
Type d’échantillonPlasma
À utiliser avec (équipement)Colorimetric Microplate Reader
Identification génétique (Entrez)P17927
Symbole de gène(s)CR1
Coefficient de variation inter-dosage<12%
Coefficient de variation intra-dosage<10%
Contenus des kitsPre-coated 96 well plate, Standard, Assay Diluent concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers
Marqueur ou colorantHRP
Quantité10 x 96 Tests
État réglementaireResearch Use Only
Volume d’échantillonSerum, 50 µL; Plasma, 50 µL; Supernatant, 50 µL
Conditions de stockage2°C to 8°C
CibleCD35
Heure du test1 hr 20 min
Durée totale du dosage4 hr 45 min
Une question, une configuration particulière ?
Contactez-nous pour un devis.